Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Card Plan Remains On White House Agenda; House Hearing Set For Oct. 3

Executive Summary

The White House is continuing to push its proposed Medicare prescription drug discount care plan as part of the sharply reduced legislative agenda for 2001.

You may also be interested in...



Healthcare Reform Returns To Political Agenda Heading Into 2002 Elections

The lessons of the 1998 and 2000 elections may encourage action on a Medicare prescription drug benefit in 2002, Republican pollster Bill McInturff said during the National Health Policy Conference in Washington, D.C., Jan. 16

Healthcare Reform Returns To Political Agenda Heading Into 2002 Elections

The lessons of the 1998 and 2000 elections may encourage action on a Medicare prescription drug benefit in 2002, Republican pollster Bill McInturff said during the National Health Policy Conference in Washington, D.C., Jan. 16

HHS Medicare Rx Card Rulemaking Planned: Fall-Back For '02 Drug Debate?

HHS is attempting to move the debate over a proposed Medicare prescription drug card discount plan out of the courtroom and into the administrative rulemaking process.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel